Maria Aivalioti

@SteidlUli @NatureGenet @SamuelJohnTayl1 Congratulations @SamuelJohnTayl1 @SteidlUli and your collaborators for the phenomenal work!!

Very happy and proud to see this study on PU.1 transcription factor "redistribution" and its mechanistic implications out in @NatureGenet today. Huge congrats to lead author @SamuelJohnTayl1! (recruiters watch out: Sam is on the faculty job market now...!). A big thank you also to the entire collaborative team including the twitterless Gregory Poon and Kristy Stengel! @EinsteinCellBio @Einstein_SCI @EinsteinMed

@GeorgiosKaragi5 congratulations 🎊 George! 🍻 To the many more!

Happy to upload our first Preprint from our lab (and hopefully one of many in the future) regarding morphometric assessment of the murine thymus using digital pathology tools and advanced imaging! Soon to engage in the long-process of publishing this! biorxiv.org/content/10.110…

Congratulations @The_Will_Lab Britta, Christine and Jiahao on this phemomenal work!! Very proud of my old colleagues and PhD lab!

@_TanyaBondar_ @BCD_AACR Congratulations, Tanya!

Blood Cancer Discovery's very first Impact Factor is released today. Huge thanks to our authors, reviewers, readers, academic board, Editors-In-Chief, in-house team of @BCD_AACR and our sister journals for reaching this mark!

@Gritsman_lab @CCR_AACR @LindsayGurska Congratulations @Gritsman_lab and @LindsayGurska !! This is so exciting!!

Excited to share our work in @CCR_AACR led by @LindsayGurska showing activity of crizotinib in myeloproliferative neoplasms, and identifying RON kinase as a new therapeutic target aacrjournals.org/clincancerres/…

#BREAKING: The U.S. FDA has approved our immunotherapy for use in combination with chemotherapy as first-line treatment in certain types of advanced #NSCLC.

We are proud to announce our #Ebola medicine, the first FDA-approved recombinant monoclonal antibody for this devastating disease, was recognized as the #PrixGalien "Best Biotechnology Product of 2022" by the @GalienFdn.

@aditishasMD right!! ✔️ 😉

Cappuccino I 💜you but my new favorite drink is Freddo espresso 🇬🇷💕

At #ESMO2022, we are sharing first-in-human data in two novel investigational bispecific antibodies in advanced solid tumors.

#BREAKING: We announced positive Phase 2 investigational data in neoadjuvant #CSCC, presented today at #ESMO22 and published in @NEJM. Learn more at the link below.

Thank you @pietras_eric, Wolfgang Schleicher and @BCD_AACR for the amazing and thoughtful commentary on our work!!

@r_piszczatowski congratulations @r_piszczatowski @EmilySchwenger @SteidlUli and team!

@ZintEleni @BCD_AACR @The_Will_Lab @Amitvermamds @TheDoctorIsVin @rosslevinemd Thank you Eleni! Congratulations 🎊 to us! 😉😃

@aivaliotim @BCD_AACR @The_Will_Lab @Amitvermamds @TheDoctorIsVin @rosslevinemd @aivaliotim congratulations 🎉🍾

Thanks @BCD_AACR - it was such a smooth and enjoyable time working with you! Thank you @The_Will_Lab, our team, @ZintEleni, our collaborators @Amitvermamds @TheDoctorIsVin @rosslevinemd, Amittha Wickrema for their immense support in progressing our work!

@GeorgiosKaragi5 @BCD_AACR @The_Will_Lab @ZintEleni @Amitvermamds @TheDoctorIsVin @rosslevinemd Thanks so much @GeorgiosKaragi5 !! 😃

@aivaliotim @BCD_AACR @The_Will_Lab @ZintEleni @Amitvermamds @TheDoctorIsVin @rosslevinemd Congratulations to you @aivaliotim, as well as to the entire team for this great piece of science!

@iannisaifantis1 @BCD_AACR @The_Will_Lab @ZintEleni @Amitvermamds @TheDoctorIsVin @rosslevinemd Thanks a lot, Ianni! 😀

@aivaliotim @BCD_AACR @The_Will_Lab @ZintEleni @Amitvermamds @TheDoctorIsVin @rosslevinemd Congratulations Maria and Team!!

@AnnaMKatsarouMD @BCD_AACR @The_Will_Lab @ZintEleni @Amitvermamds @TheDoctorIsVin @rosslevinemd Σε ευχαριστώ/ούμε πολύ Άννα μου!! 😀

@aivaliotim @BCD_AACR @The_Will_Lab @ZintEleni @Amitvermamds @TheDoctorIsVin @rosslevinemd Θερμά συγχαρητήρια Μαρία μου!!! Congratulations to everyone!! Awesome work!!!🎉🎉🎉

@BCD_AACR @EinsteinMed 2/2 @Gamble__Lab @TDBhagat and Winfried Edelmann, among others, for their insightful advice and support in getting this project advace!

PU.1-dependent enhancer inhibition separates Tet2-deficient #hematopoiesis from malignant transformation, by @aivaliotim et al. bit.ly/3yFU5qn @EinsteinMed

@BCD_AACR @EinsteinMed 1/1 Thanks @BCD_AACR - such a smooth and enjoyable time working with you!Thank you Britta Will, @The_Will_Lab, our team, especially @ZintEleni, our collaborators @Amitvermamds @TheDoctorIsVin @rosslevinemd, Amittha Wickrema and many more people @SteidlUli @Gritsman_lab @MDawlaty